These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11268318)

  • 1. Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
    Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
    Haematologica; 2000 Nov; 85(11 Suppl):18-25. PubMed ID: 11268318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle.
    Lucotti C; Malabarba L; Rosti V; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Ramajoli I; Perotti C; Torretta L; De Amici M; Salvaneschi L; Cazzola M
    Br J Haematol; 2000 Mar; 108(3):621-8. PubMed ID: 10759722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
    Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement.
    Nadali G; de Wynter EA; Perandin F; Tavecchia L; Vincenzi C; Ambrosetti A; Fornalè M; Perona G; Pizzolo G; Testa NG
    Haematologica; 1998 Dec; 83(12):1059-65. PubMed ID: 9949621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is in vitro expansion of human cord blood cells clinically relevant?
    Denning-Kendall PA; Nicol A; Horsley H; Donaldson C; Bradley B; Hows JM
    Bone Marrow Transplant; 1998 Feb; 21(3):225-32. PubMed ID: 9489644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of in vitro expansion of cord blood.
    Denning-Kendall PA; Horsley H; Nicol A; Nieda M; Bradley B; Hows JM
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S63-5. PubMed ID: 9715893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].
    Ma Y; Zou P; Xiao J; Huang S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):330-3. PubMed ID: 11953192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the cycling of clonogenic and primitive cord blood progenitors by various growth factors.
    Movassagh M; Caillot L; Baillou C; Guigon M; Lemoine FM
    Stem Cells; 1997; 15(3):214-22. PubMed ID: 9170213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations.
    Jordan CT; Yamasaki G; Minamoto D
    Exp Hematol; 1996 Sep; 24(11):1347-55. PubMed ID: 8862447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor and the amplification of progenitor cells from CD34+ cord blood cells.
    Migliaccio AR; Baiocchi M; Durand B; Eddleman K; Migliaccio G; Adamson JW
    Blood Cells; 1994; 20(1):129-38; discussion 138-9. PubMed ID: 7527676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult.
    Hennemann B; Ickenstein G; Sauerbruch S; Luecke K; Haas S; Horn M; Andreesen R; Bogdahn U; Winkler J
    Cytotherapy; 2008; 10(3):303-11. PubMed ID: 18418775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells.
    Kögler G; Radke TF; Lefort A; Sensken S; Fischer J; Sorg RV; Wernet P
    Exp Hematol; 2005 May; 33(5):573-83. PubMed ID: 15850835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.